Monica Muñoz

17PUBLICATIONS
44CO-AUTHORS
Characterisation of biological macromoleculesInformation systems development methodologies and practiceAuditing and accountabilityMedicinal and biomolecular chemistry not elsewhere classifiedDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|Sep 07, 2026
Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.

|Oct 09, 2025
Recommendations to Enable Broader Use of Real-World Evidence to Inform Decision-Making Throughout Pharmacovigilance Signal Management.

G Niklas Norén, Katherine Donegan, Monica A Muñoz

|Jun 04, 2025
An Evaluation of Duplicate Adverse Event Reports Characteristics in the Food and Drug Administration Adverse Event Reporting System.

Scott Janiczak, Sarah Tanveer, Karen Tom

|Feb 11, 2025
Severe gastrointestinal adverse reactions including perforation, ulceration, hemorrhage, and obstruction: A fumaric acid ester class new safety risk.

Tiffany Kim, Allen Brinker, David Croteau

|Jun 06, 2024
Trust but Verify: Lessons Learned for the Application of AI to Case-Based Clinical Decision-Making From Postmarketing Drug Safety Assessment at the US Food and Drug Administration.

Robert Ball, Andrew H Talal, Oanh Dang

|Mar 11, 2024
Fibrosing colonopathy associated with cysteamine bitartrate delayed-release capsules in cystinosis patients.

Omayma A Kishk, Ivone Kim, Carmen Cheng

Pageof 3

Frequent Collaborators

4 joint publications

Gerald J Dal Pan

3 joint publications

Cindy M Kortepeter

3 joint publications

Lisa Wolf

3 joint publications

Carmen Cheng